Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nosocomial pneumonia

J Chastre1, J L Trouillet

  • 1Service de Réanimation Médicale, Hôpital Bichat-Claude Bernard, Paris, France.

Current Opinion in Pulmonary Medicine
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Nosocomial pneumonia is a common issue for ventilator patients. Research highlights nasal intubation as a risk, while sucralfate shows promise for prevention, though antibiotic strategies need further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus treated with linezolid or vancomycin: A secondary economic analysis of resource use from a Spanish perspective.

Medicina intensiva·2016
Same author

Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: a call for international guidelines.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Same author

Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same author

Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Nosocomial pneumonia (NP) is a significant complication in intensive care unit (ICU) patients requiring mechanical ventilation.
  • Despite advances in infection control, NP remains prevalent, necessitating ongoing research into optimal management strategies.
  • Recent literature reviews address critical issues in managing ventilator-associated pneumonia (VAP).

Purpose of the Study:

  • To review recent advances and critical issues in the management of nosocomial pneumonia in ventilator-dependent patients.
  • To evaluate risk factors, preventive strategies, diagnostic techniques, and therapeutic approaches for NP.

Main Methods:

  • Review of recently published articles on nosocomial pneumonia in ICU settings.

Related Experiment Videos

  • Analysis of data concerning risk factors, diagnostic methods (protected specimen brush, bronchoalveolar lavage), and therapeutic interventions.
  • Evaluation of controversial strategies like selective digestive decontamination and promising agents like sucralfate.

    • Main Results:

    • Nasal intubation identified as a major risk factor for nosocomial infections in mechanically ventilated patients.
    • Selective digestive decontamination remains controversial due to resistance concerns, but sucralfate shows potential for preventing late-onset pneumonia.
    • Protected specimen brush and bronchoalveolar lavage reliably identify lung microorganisms, even in superinfections during antimicrobial therapy.

    Conclusions:

    • Optimal management of nosocomial pneumonia in ICU patients requires careful consideration of risk factors and diagnostic accuracy.
    • Sucralfate may offer a promising preventive strategy for late-onset pneumonia.
    • Further clinical trials are essential to define the role of antibiotic monotherapy in treating nosocomial pneumonia.